Eiropas Savienība - latviešu - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Latvija - latviešu - Zāļu valsts aģentūra

tarchomin pharmaceutical works "polfa" s.a., poland - rifampicīns - kapsula, cietā - 300 mg

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 un 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 un 5.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Latvija - latviešu - Zāļu valsts aģentūra

berlin-chemie ag, germany - levotiroksīna nātrija sāls - tablete - 25 μg

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

pfizer ltd. - sitaksenta nātrija sāls - hipertensija, plaušu slimība - antihipertensīvie līdzekļi, - pacienti ar pulmonālu arteriālo hipertensiju (pah), kas klasificēti kā pvo iii funkcionālā klase, lai uzlabotu fizisko slodzi. efektivitāte ir pierādīta primārajā plaušu hipertensijā un plaušu hipertensijā, kas saistīta ar saistaudu slimību.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - cukura diabēts, 2. tips - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - hipertensija, plaušu slimība - antihipertensīvie līdzekļi, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - cukura diabēts - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 un 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

janssen-cilag international nv - rilpivirīns - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.